Advertisement
U.S. markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed Price. Currency in USD
580.05-4.10 (-0.70%)
At close: 04:00PM EDT
590.96 +10.91 (+1.88%)
After hours: 08:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close584.15
Open585.86
Bid565.48 x 800
Ask595.63 x 800
Day's Range578.30 - 586.84
52 Week Range415.60 - 603.82
Volume1,453,083
Avg. Volume1,594,631
Market Cap221.18B
Beta (5Y Monthly)0.80
PE Ratio (TTM)37.59
EPS (TTM)15.43
Earnings DateApr 24, 2024 - Apr 29, 2024
Forward Dividend & Yield1.56 (0.27%)
Ex-Dividend DateMar 14, 2024
1y Target Est596.99
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-15% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TMO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Thermo Fisher Scientific Inc
    Weekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
    Rating
    Fair Value
    Economic Moat
    16 hours agoArgus Research
View more
  • Zacks

    Thermo Fisher Scientific (TMO) Stock Falls Amid Market Uptick: What Investors Need to Know

    Thermo Fisher Scientific (TMO) reachead $580.05 at the closing of the latest trading day, reflecting a -0.7% change compared to its last close.

  • Insider Monkey

    20 Most Owned Stocks by Hedge Funds Now

    In this article, we will be taking a look at the 20 most owned stocks by hedge funds now. To skip our detailed analysis of the current stock market news, you can go directly to see the 5 Most Owned Stocks by Hedge Funds Now. Rate Cuts in June As the US economy continues to […]

  • Insider Monkey

    12 Most Profitable Biotech Stocks To Invest In

    In this piece, we will take a look at the 12 most profitable biotech stocks to invest in. If you want to skip our overview of the global biotechnology industry and the latest trends, then you can take a look at the 5 Most Profitable Biotech Stocks To Invest In. Biotechnology is the riskiest and […]